Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging study of SB 683699 in relapsing multiple sclerosis
2004-000374-31Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of firategrast in multiple sclerosis (MS) (3 arms), sponsored by GSK. Started Aug 2004; status: completed.
02
Drugs
firategrast
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-000374-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000374-31.